...
...
Next Story

India’s Covid-19 count now closer to 9.4 million, 22 states and UTs have fatality rate lower than national average

The Union health ministry posted a graph on Sunday morning, which showed that 22 states and union territories have Covid-19 fatality rate lower than the national average of 1.46 per cent.

Updated on: Nov 29, 2020, 09:35:23 IST
Hindustan Times, New Delhi | By
Prefer HTon Google
Advertisement

India’s coronavirus disease (Covid-19) count reached 93,92,919 on Sunday after 41,810 new cases were recorded in the last 24 hours, according to Union health ministry.

Health workers preserve swab samples collected from passengers arriving from other states, to test for coronavirus infection at Anand Vihar Bus Terminal in New Delhi on Thursday. (Biplov Bhuyan/HT File Photo)
Health workers preserve swab samples collected from passengers arriving from other states, to test for coronavirus infection at Anand Vihar Bus Terminal in New Delhi on Thursday. (Biplov Bhuyan/HT File Photo)

The number of active cases stand at 4,53,956, while 88,02,267 people have been cured or discharged.

The country also recorded 496 new fatalities due to the coronavirus disease, which pushed the death toll up to 1,36,696, according to health ministry update at 8 am.

The ministry posted a graph on Sunday morning, which showed that 22 states and union territories have Covid-19 fatality rate lower than the national average of 1.46 per cent.

Prime Minister Narendra Modi, meanwhile, held a three-city tour to Pune, Ahmedabad and Hyderabad on Saturday to personally review the development and manufacturing of the vaccine.

The Prime Minister’s visit to Pune’s Serum Institute of India (SII), Ahmedabad’s Zydus Biotech Park and Hyderabad’s Bharat Biotech earlier today was aimed at getting the first-hand perspective of the preparations, challenges and roadmap in the country’s endeavour to vaccinate its citizens.

PM Modi also met SII chief Adar Poonawalla, who said after the meeting that his company will apply for an emergency approval for the coronavirus vaccine developed by University of Oxford and AstraZeneca in two weeks.

The vaccine being developed by Oxford and AstraZeneca had shown to be at least 62 per cent (and up to 90 per cent) effective in an interim analysis based on 131 infections in the clinical trials being held in the United Kingdom and Brazil.

 
Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.
Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather and major national developments.
SHARE THIS ARTICLE ON
Hindustantimes wants to start sending you push notifications. Click allow to subscribe